
Dobbin spoke with The Sick Times about her open letters to U.K. Prime Minister Andy Burnham advocating for ME research, the response to and toll of her advocacy, and what the mainstream media has missed about her story.

Two prominent conferences covering Long COVID, postural orthostatic tachycardia syndrome (POTS), and related diseases occurred this past week. Early results from trials were shared at both the American Autonomic Society (AAS)’s 37th International Symposium on the Autonomic Nervous System in San Diego, California, and the 4th Long COVID International Conference in Nice, France.

A new study found that people with hypermobile Ehlers-Danlos Syndrome (hEDS) were three times more likely to develop Long COVID than those without the syndrome. The study was published in PLOS Digital Health and assessed the electronic health records of nearly 20 million Americans.

Multiple COVID-19 precautions during the Tokyo Olympic and Paralympic Games were effective in minimizing SARS-CoV-2 transmission, according to a new study in Eurosurveillance. Using retrospective epidemiological data, Japanese researchers found that spread was very low during the games, as most cases occurred during arrival or mandatory quarantines before the games.

Low-dose prednisolone may temporarily reduce some “symptom severity” of Long COVID, according to a new study in eClinicalMedicine. German researchers evaluated the drug, a corticosteroid that reduces inflammation and is used to treat a broad range of conditions, alongside some B vitamins, in the phase 3 clinical trial.

A large Long COVID review found mechanisms of “accelerated biological aging” in young adults. The review was published in Ageing Research Reviews and synthesized 110 mechanistic and epidemiological Long COVID studies on adults ages 25–55.

A new study found COVID-19 was linked to a significant increase in dementia in older people with type 2 diabetes. The retrospective study published in Frontiers in Aging Neuroscience included a cohort of nearly half a million people with documented SARS-C0V-2 infections.

As many as 2.3 million new cases of cancer were triggered by viral infections worldwide in 2024, according to new research in The Lancet Oncology. French researchers analyzed a large database of cancer incidence from 2024, looking at specific diagnoses that were attributable to infections.

A small clinical trial found Remdesivir was safe for people with Long COVID and that some exploratory results warrant a larger trial. The U.K. trial, which included 73 participants who took a five day course of the intravenous antiviral COVID-19 drug, was published in Oxford Open Immunology.

A small study in NeuroImage: Reports has found more evidence of reduced blood flow to the brain of people with Long COVID. The authors concluded that this abnormality was linked with fatigue, after they assessed brain imaging results of 22 people with Long COVID and compared them with 19 controls.
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance